A Clinical and Biochemical Study of Monoamine Oxidase Inhibition in Depressed Patients
- 1 March 1961
- journal article
- research article
- Published by Royal College of Psychiatrists in Journal of Mental Science
- Vol. 107 (447) , 244-249
- https://doi.org/10.1192/bjp.107.447.244
Abstract
In order to test whether a drug is an inhibitor of monoamine oxidase in the human subject, three main measures are available:1. We can measure an increased excretion of the normal substrates of the enzyme, e.g. tryptamine (Sjoerdsma,et al., 1959b).2. We can measure a decreased excretion of the metabolites resulting from the enzyme's action, e.g. 5-hydroxyindoleacetic acid (5-HIAA).3. We can administer a loading dose of an enzyme substrate and observe how the subject deals with it before and after the drug, e.g. 5-hydroxytryptamine (Sjoerdsmaet al., 1958), and epinephrine (N-methyl-C14) (Resnicket al., 1958).Keywords
This publication has 5 references indexed in Scilit:
- IDENTIFICATION AND ASSAY OF URINARY TRYPTAMINE: APPLICATION AS AN INDEX OF MONOAMINE OXIDASE INHIBITION IN MANThe Journal of Pharmacology and Experimental Therapeutics, 2025
- Physiologically active amines in common fruits and vegetablesArchives of Biochemistry and Biophysics, 1959
- A METHOD FOR MEASUREMENT OF MONOAMINE OXIDASE INHIBITION IN MAN: APPLICATION TO STUDIES ON HYPERTENSIONAnnals of the New York Academy of Sciences, 1959
- Iproniazid Treatment and Metabolism of Labeled Epinephrine in SchizophrenicsScience, 1958
- THE IDENTIFICATION OF 5-HYDROXY-3-INDOLEACETIC ACID IN NORMAL URINE AND A METHOD FOR ITS ASSAYJournal of Biological Chemistry, 1955